Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Evox Therapeutics Appoints Dr. Per Lundin As Chief Executive Officer

PRIVATEApr 29, 2024•about 2 years ago

Position

Chief Executive Officer

Company

Evox Therapeutics Ltd

Per Lundin
OxfordBiotechnologyHealth CareTherapeutics

Description

Evox Therapeutics has appointed Dr Per Lundin, Co-Founder and Chief Business Officer, as the new Chief Executive Officer (CEO) of the Company. Dr Antonin de Fougerolles has decided to step down as CEO and Director of Evox, and will continue to support the Company as a strategic adviser.

Company Information

Company

Evox Therapeutics Ltd

Location

Oxford, England, United Kingdom

About

Evox Therapeutics is a privately held, Oxford-based biotechnology company that is a leader in harnessing and engineering the natural delivery capabilities of exosomes to create and enable the next generation of genetic medicines. Evox uses its DeliverEX® platform to engineer exosomes to facilitate safe and precise drug delivery to hard-to-reach organs and tissues.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Evox Therapeutics Ltd's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.